Publication | Open Access

Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes

Phase 1BEfficacy Measure OutcomesOcular DiseaseOphthalmologyExperimental OphthalmologyRandomized Controlled StudyNeurologyGlaucomaMedicine